Hereditary Leiomyomatosis and Renal Cell Carcinoma
Oncology·MeSH: Hereditary leiomyomatosis and renal cell cancer
Prevalence
48.0 / 100K
Incidence
15.0 / 100K/yr
5 drugs in development·2 companies·1 clinical trial
Drug Pipeline by Phase
Compare drugs
Frequently asked questions
How many drugs are in development for Hereditary Leiomyomatosis and Renal Cell Carcinoma?
BioSniper tracks 5 drugs in development for Hereditary Leiomyomatosis and Renal Cell Carcinoma across 2 companies.
How many clinical trials target Hereditary Leiomyomatosis and Renal Cell Carcinoma?
There are 1 clinical trial targeting Hereditary Leiomyomatosis and Renal Cell Carcinoma tracked by BioSniper.
What is the prevalence of Hereditary Leiomyomatosis and Renal Cell Carcinoma?
The estimated prevalence of Hereditary Leiomyomatosis and Renal Cell Carcinoma is approximately 48.0 per 100,000 population.
Deep-dive into Hereditary Leiomyomatosis and Renal Cell Carcinoma
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis